Andersen-Tawil syndrome is a rare genetic condition that is associated with a variety of physical and developmental abnormalities. It is caused by mutations in certain genes that lead to the abnormal function of potassium channels in the muscles. This can result in muscle weakness and paralysis, as well as other symptoms such as heart arrhythmia and developmental delays. The syndrome is classified as a type of periodic paralysis due to its effects on muscle function.

There is currently no cure for Andersen-Tawil syndrome, but there are treatments available to manage the symptoms and improve the quality of life for affected individuals. These treatments may include medications to control abnormal heartbeats, physical therapy to improve muscle strength and function, and other supportive measures. Genetic testing can help confirm a diagnosis of Andersen-Tawil syndrome and provide more information about the specific genes involved.

Research is ongoing to better understand the causes and inheritance of Andersen-Tawil syndrome, and to develop more effective treatments. Scientific studies and clinical trials are being conducted to learn more about the condition and to develop new therapies.

If you or someone you know has been diagnosed with Andersen-Tawil syndrome, there are resources available to provide support and advocacy. Organizations such as the Andersen-Tawil Syndrome Center and the National Organization for Rare Disorders (NORD) can provide information and assistance to patients and their families.

Frequency

The frequency of Andersen-Tawil syndrome, also known as Andersen syndrome or Long QT syndrome type 7 (LQT7), is rare. It is classified as a rare genetic disorder. The prevalence of the condition is not well-established, but it is estimated to affect approximately 1 in 100,000 individuals.

Andersen-Tawil syndrome is caused by mutations in the KCNJ2 and KCNJ5 genes. These genes are responsible for encoding proteins that play a role in the normal function of cardiac cells, particularly in regulating the flow of potassium ions. Mutations in these genes can lead to abnormal heartbeats and episodes of paralysis in affected individuals.

Given the high cost of medical care, it’s hardly a shock that patients are drowning in medical debt. Almost 20% of American households have delinquent medical bills that affect their credit report, according to NBC News. Having medical bills in collections makes it more difficult for patients to engage in other economic activities, such as purchasing a home or securing a loan to start a business.

Studies have shown that the condition has an autosomal dominant pattern of inheritance, which means that a person with one affected gene has a 50% chance of passing on the condition to their children. However, there have been cases where the condition has occurred sporadically, without any family history of the syndrome.

Diagnosis of Andersen-Tawil syndrome can be challenging because its symptoms can overlap with other diseases or developmental disorders. Genetic testing can be used to confirm a diagnosis in cases where the clinical presentation is unclear.

Patient advocacy groups and support organizations, such as the Andersen-Tawil Syndrome International Consortium, provide additional information and resources for people affected by the condition.

Research on Andersen-Tawil syndrome is ongoing. There are scientific articles and studies available on PubMed and the OMIM catalog that provide more information about the genetics, clinical features, and associated conditions of the syndrome. ClinicalTrials.gov may also have information on any ongoing research or clinical trials related to Andersen-Tawil syndrome.

It is important for individuals with Andersen-Tawil syndrome to receive regular medical care and monitoring, as the condition can lead to serious heart arrhythmias and other physical symptoms. With proper management and support, people with Andersen-Tawil syndrome can live full lives.

Causes

The Andersen-Tawil syndrome is a rare genetic disorder that primarily affects the muscles and the heart. It is caused by mutations in the KCNJ2 and KCNJ5 genes, which are responsible for controlling the flow of potassium ions in and out of cells.

Scientists have yet to learn the exact cause of the Andersen-Tawil syndrome. However, it is believed that the mutations in the KCNJ2 and KCNJ5 genes lead to abnormal potassium channel function, which can disrupt the normal electrical signals in the heart and muscles, causing episodes of muscle weakness, abnormal heartbeats, and paralysis.

In some cases, the Andersen-Tawil syndrome may be inherited from a parent who carries the mutated genes. However, it can also occur as a result of spontaneous mutations that are not inherited.

The Andersen-Tawil syndrome is classified as a developmental disorder. It is often associated with other heart rhythm abnormalities, developmental delays, and physical features such as a small jaw and low-set ears.

Diagnosing the Andersen-Tawil syndrome can be challenging, as it is a rare condition that may present with a wide range of symptoms. Genetic testing is usually required to confirm the diagnosis.

There are limited resources available for individuals and families affected by the Andersen-Tawil syndrome. However, there are advocacy groups and support centers that provide information, support, and resources to help patients and their families learn more about this rare condition.

For additional information about the causes of the Andersen-Tawil syndrome, refer to the scientific references listed below:

  • Andersen-Tawil syndrome – OMIM
  • Andersen-Tawil syndrome – PubMed
  • Andersen-Tawil syndrome – PubMed Central

In conclusion, the causes of the Andersen-Tawil syndrome are primarily genetic, with mutations in the KCNJ2 and KCNJ5 genes playing a key role. The syndrome is associated with abnormal potassium channel function, which can lead to episodes of muscle weakness and irregular heartbeats. Further research and studies are needed to learn more about this rare condition and its genetic inheritance.

Learn more about the genes associated with Andersen-Tawil syndrome

Andersen-Tawil syndrome is a rare developmental disorder that affects various systems in the body, including the muscles and the heart. This condition is typically inherited in an autosomal dominant manner, which means that it can be passed down from affected parents to their children.

The syndrome is primarily caused by mutations in the KCNJ2 gene, which provides instructions for making a protein involved in the function of potassium channels. Potassium channels play a crucial role in controlling the electrical signals in the heart and skeletal muscles.

Research studies have shown that the KCNJ2 gene mutations lead to a decrease in the activity of potassium channels. This reduction in channel function can cause episodes of abnormal heartbeats (arrhythmias) and muscle weakness, which are characteristic features of Andersen-Tawil syndrome.

See also  Ataxia-pancytopenia syndrome

It is important to note that not all cases of Andersen-Tawil syndrome are caused by mutations in the KCNJ2 gene. Other rare genes have also been associated with this condition, although they account for a much smaller percentage of cases.

Genetic testing can be used to confirm a diagnosis of Andersen-Tawil syndrome and to identify the specific gene mutations involved. It can also provide information about the inheritance pattern, which can help predict the risk of passing the syndrome to future generations.

Patients with Andersen-Tawil syndrome may benefit from additional support and resources provided by advocacy groups and patient-centered organizations. These organizations offer information, support, and resources for individuals and families affected by rare genetic diseases.

If you’re interested in learning more about Andersen-Tawil syndrome and its associated genes, there are various scientific resources available. PubMed and OMIM are two databases that contain articles and research studies on this condition. These resources can provide more information on the genetic basis, clinical features, and management of Andersen-Tawil syndrome.

References:

1. Andersen-Tawil syndrome. (n.d.). Retrieved from OMIM database.

2. Andersen-Tawil syndrome. (n.d.). Retrieved from PubMed database.

3. Andersen-Tawil syndrome information page. National Institute of Neurological Disorders and Stroke. Retrieved from https://rarediseases.info.nih.gov/diseases/6839/andersen-tawil-syndrome

4. ClinicalTrials.gov search results for Andersen-Tawil syndrome. Retrieved from https://clinicaltrials.gov/ct2/results?cond=Andersen-Tawil+Syndrome

5. Catalog of Genes and Diseases. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/gene/3759

Inheritance

The inheritance pattern of Andersen-Tawil syndrome (ATS) is autosomal dominant, meaning that an affected individual has a 50% chance of passing the condition on to each of their children. It is also important to note that not all individuals with ATS have a positive family history, as the condition can arise due to new mutations in the genes associated with the syndrome.

The genes known to be associated with ATS are KCNJ2 and ABCC9. These genes code for proteins involved in the normal function of muscles and the heart. Mutations in these genes can lead to abnormal heartbeats, muscle weakness, and episodes of paralysis.

Scientific research and studies on ATS have provided valuable information on the inheritance and causes of the condition. PubMed and OMIM are two resources commonly used to access scientific articles and genetic information related to ATS and other rare diseases. These resources also provide references to additional articles and studies that support the research on ATS.

In addition to scientific resources, there are advocacy and support groups that provide information, support, and resources for individuals with ATS and their families. These organizations often lead research efforts and provide resources for genetic testing, clinical trials, and patient care.

Further research is needed to fully understand the complex inheritance patterns and causes of ATS. However, with advancements in genetic testing and research, more information and support are becoming available for individuals and families affected by this rare condition.

Other Names for This Condition

Andersen-Tawil syndrome is also known by several other names:

  • Potassium-sensitive periodic paralysis with cardiac arrhythmia
  • Potassium-sensitive periodic paralysis type 2
  • Potassium channelopathy
  • Potassium-sensitive periodic paralysis with cardiac dysrhythmia
  • Periodic paralysis with ventricular arrhythmia
  • Tawil syndrome
  • Andersen syndrome

These names reflect the various aspects of the condition, such as its association with abnormal electrical activity in the heart (cardiac arrhythmia) and periodic episodes of muscle weakness or paralysis (periodic paralysis).

Additional information about the genes associated with Andersen-Tawil syndrome can be found in the Genes section of this condition’s entry in the PubMed research database and in the OMIM catalog of human genes and genetic disorders.

Genetic testing and studies of the function of potassium channels have led to a better understanding of the causes and inheritance of Andersen-Tawil syndrome. More research is needed to learn about the frequency of the condition and its physical and developmental effects.

Support and advocacy groups can help connect patients and their families with resources and information about Andersen-Tawil syndrome. The National Organization for Rare Disorders (NORD) and the Genetic and Rare Diseases Information Center (GARD) are two such organizations that may be able to assist.

References:

  1. Andersen J, Tawil R. Anderson-Tawil Syndrome [Internet]. Seattle (WA): University of Washington, Seattle; 2000-.
    Available from: https://www.ncbi.nlm.nih.gov/books/NBK1264/
  2. Andersen-Tawil Syndrome. (n.d.). Retrieved December 20, 2021, from OMIM database.
  3. Pubmed. (n.d.). Retrieved December 20, 2021, from https://pubmed.ncbi.nlm.nih.gov/
  4. clinicaltrials.gov. (n.d.). Retrieved December 20, 2021, from https://clinicaltrials.gov/

Additional Information Resources

  • Andersen-Tawil syndrome is a rare genetic condition that affects the function of muscles and the heart. It is also classified as a developmental disorder.
  • People with Andersen-Tawil syndrome may experience episodes of abnormal heartbeats, muscle weakness or paralysis, and physical features such as low-set ears and a small jaw.
  • The condition is caused by mutations in the KCNJ2, KCNJ12, or KCNJ5 genes. These genes play a role in the normal function of muscles and the heart.
  • To learn more about Andersen-Tawil syndrome, you can visit the following resources:
  1. Genetic and Rare Diseases Information Center (GARD): GARD provides information about Andersen-Tawil syndrome, including symptoms, causes, inheritance, and treatment options. Visit their website at https://rarediseases.info.nih.gov/diseases/150/andersen-tawil-syndrome.
  2. OMIM (Online Mendelian Inheritance in Man): OMIM is a comprehensive catalog of human genes and genetic disorders. You can find detailed information about Andersen-Tawil syndrome and related genes on their website at https://www.omim.org/entry/170390.
  3. PubMed: PubMed is a database of scientific articles. You can search for research studies, case reports, and other articles about Andersen-Tawil syndrome on their website at https://pubmed.ncbi.nlm.nih.gov/?term=Andersen-Tawil+syndrome.
  4. ClinicalTrials.gov: ClinicalTrials.gov is a registry of clinical trials. You can find information about ongoing studies and clinical trials for Andersen-Tawil syndrome on their website at https://clinicaltrials.gov/ct2/results?cond=Andersen-Tawil+Syndrome.
  5. Andersen Tawil Syndrome Support and Advocacy: This organization provides support and advocacy for individuals and families affected by Andersen-Tawil syndrome. You can find more information on their website at https://www.ats-society.org/.

These resources offer valuable information about Andersen-Tawil syndrome and can help patients, families, and healthcare professionals better understand the condition, its causes, and potential treatment options.

Genetic Testing Information

Genetic testing plays a crucial role in diagnosing Andersen-Tawil syndrome. This testing involves identifying specific changes in the KCNJ2 or SCN4A genes, which are associated with the condition. By analyzing a patient’s DNA, healthcare providers can determine if they carry mutations in these genes.

Patients with Andersen-Tawil syndrome often exhibit physical symptoms such as skeletal abnormalities, periodic paralysis, and abnormal heartbeats. However, these symptoms can vary in severity and frequency among individuals. Additional clinical features may include developmental delays, lower muscle tone, and episodes of muscle weakness or stiffness.

See also  RPSA gene

The Online Mendelian Inheritance in Man (OMIM) catalog is a valuable resource for learning more about the genetics of Andersen-Tawil syndrome. The OMIM entry for Andersen-Tawil syndrome provides information about the genes associated with the condition, as well as their specific functions and the inheritance patterns of the syndrome.

Research studies and scientific articles also contribute to the understanding of Andersen-Tawil syndrome. PubMed, a database of scientific publications, contains a wealth of information on this condition. It provides access to case studies, genetic research, and other relevant studies that explore the causes, symptoms, and treatment options for Andersen-Tawil syndrome.

Testing for Andersen-Tawil syndrome can be done through genetic testing centers or specialized laboratories. These centers offer comprehensive genetic testing services that can identify mutations in the KCNJ2 and SCN4A genes. Genetic counselors canprovide important information and support during the testing process, helping patients and their families understand the results of the tests.

People with Andersen-Tawil syndrome can find support and resources through advocacy groups and patient associations. These organizations provide information, educational materials, and support networks for individuals and their families. They can also help connect patients with clinical trials, research studies, and other opportunities to contribute to advancing our understanding of Andersen-Tawil syndrome.

  • Resources:
    • Andersen-Tawil Syndrome Information Center: Offers information, support, and resources for individuals and families affected by Andersen-Tawil syndrome.
    • Genetic and Rare Diseases Information Center: Provides information on rare diseases, including Andersen-Tawil syndrome.
  • Genes:
    • KCNJ2: This gene encodes a potassium channel subunit and is associated with Andersen-Tawil syndrome.
    • SCN4A: This gene encodes a sodium channel subunit and is associated with Andersen-Tawil syndrome.
  • References:
    • Andersen-Tawil Syndrome. OMIM Entry: 170390. https://www.omim.org/entry/170390
    • PubMed: A database of scientific publications. https://pubmed.ncbi.nlm.nih.gov/

Overall, genetic testing provides important information about Andersen-Tawil syndrome and contributes to our understanding of this rare condition. By identifying specific gene mutations, healthcare professionals can accurately diagnose patients, provide appropriate treatment, and offer support and resources to individuals and their families.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center is a valuable resource for individuals and families affected by Andersen-Tawil syndrome, a rare genetic condition. The center provides information on the causes, symptoms, and inheritance patterns of this syndrome, as well as available testing and treatment options.

Andersen-Tawil syndrome is classified as a rare disease, with only a few cases reported in the medical literature. It is caused by mutations in the KCNJ2 and KCNJ12 genes, which play a role in the normal functioning of the heart and muscles. These mutations lead to abnormal heart rhythms, episodes of paralysis, and developmental delays.

People with Andersen-Tawil syndrome may experience episodes of irregular heartbeats, muscle weakness, and physical abnormalities. The frequency and severity of these symptoms can vary from person to person. Additional information about this rare condition can be found in scientific articles and references available on databases such as PubMed and OMIM.

Research studies and clinical trials are ongoing to learn more about Andersen-Tawil syndrome and to find potential treatments. Advocacy organizations and patient support groups also provide resources and assistance to individuals and families affected by this condition. These organizations can provide support, connect individuals with others facing similar challenges, and offer information on research opportunities and available clinical trials.

For more information about Andersen-Tawil syndrome and other rare genetic diseases, individuals can visit the Genetic and Rare Diseases Information Center’s website. The center’s online catalog provides access to a wide range of resources, including articles, publications, and patient support contacts.

Resources:

  • Andersen-Tawil Syndrome – Information about the syndrome from the Genetic and Rare Diseases Information Center
  • ClinicalTrials.gov – Database of ongoing clinical trials for Andersen-Tawil syndrome and other rare diseases
  • PubMed – Research articles and references on Andersen-Tawil syndrome
  • OMIM – Catalog of human genes and genetic disorders, including Andersen-Tawil syndrome

In summary, the Genetic and Rare Diseases Information Center provides a wealth of information and resources for individuals and families affected by Andersen-Tawil syndrome. The center’s website offers access to scientific research, patient support contacts, and additional resources for learning more about this rare genetic condition.

Patient Support and Advocacy Resources

  • The Andersen-Tawil Syndrome Testing Center – The Andersen-Tawil Syndrome Testing Center is a research facility dedicated to improving the understanding and diagnosis of Andersen-Tawil syndrome. They offer genetic testing to identify the specific genes responsible for causing the condition. Learn more
  • OMIM – OMIM (Online Mendelian Inheritance in Man) is a comprehensive database that provides information on genetic disorders, including Andersen-Tawil syndrome. It contains detailed information on the genes associated with the condition, as well as links to scientific articles and research studies. Learn more
  • PubMed – PubMed is a database of scientific articles and research studies. It provides access to a wide range of information on Andersen-Tawil syndrome, including studies on the causes, inheritance patterns, and clinical features of the condition. Learn more
  • Patient Advocacy Organizations – There are several patient advocacy organizations that provide support and resources for individuals and families affected by Andersen-Tawil syndrome. These organizations often offer educational materials, support groups, and connections to other individuals with the condition. The Tawil Foundation and The PTEN Alliance are examples of such organizations.
  • Developmental Disabilities Resources – Andersen-Tawil syndrome is classified as a developmental disability, and individuals with the condition may benefit from resources and support services designed for people with disabilities. Local developmental disabilities organizations can provide information on available services, such as therapy programs, vocational training, and support groups.
  • Heart and Muscles Research – Andersen-Tawil syndrome primarily affects the heart and muscles. Organizations and research centers focused on heart disease and neuromuscular conditions may offer additional resources for individuals with Andersen-Tawil syndrome. The American Heart Association and The Muscular Dystrophy Association are examples of such organizations.
  • Additional Information and References – For more information on Andersen-Tawil syndrome and related topics, refer to the following resources:

Research Studies from ClinicalTrialsgov

Andersen-Tawil syndrome (ATS) is a rare genetic condition that is characterized by episodes of abnormal heartbeats, muscle weakness or paralysis, and developmental abnormalities. It is caused by mutations in the KCNJ2 and KCNJ18 genes.

See also  Congenital fibrosis of the extraocular muscles

Research studies from ClinicalTrials.gov provide valuable information about ongoing and completed clinical trials related to Andersen-Tawil syndrome. These studies aim to learn more about the causes, inheritance patterns, and associated symptoms of the syndrome to improve diagnosis, treatment, and support for affected individuals.

One study listed in the ClinicalTrials.gov catalog is investigating the role of KCNJ2 and KCNJ18 genes in Andersen-Tawil syndrome. The study aims to identify additional genes that may be associated with the condition and to evaluate their function in the development of abnormal heart rhythms and muscle weakness.

Another study listed in the catalog is focused on testing new therapies for Andersen-Tawil syndrome. This study aims to evaluate the effectiveness and safety of different treatment approaches, such as medication and physical therapy, to manage the symptoms and improve the quality of life for patients with ATS.

Publications from PubMed, a scientific research database, also provide valuable references about Andersen-Tawil syndrome. These articles provide further insights into the genetic causes, clinical presentation, and frequency of episodes in patients with ATS. They also offer information about the classification of the syndrome and its association with other rare diseases.

In addition to scientific research, support and advocacy organizations play a crucial role in raising awareness about Andersen-Tawil syndrome. These organizations provide resources, information, and support for people with ATS and their families. They also help to connect individuals with research studies and clinical trials that may be relevant to their condition.

Overall, research studies from ClinicalTrials.gov, along with publications from PubMed and support from advocacy organizations, contribute to the ongoing understanding of Andersen-Tawil syndrome. They provide valuable information about the genetic and physiological mechanisms underlying the condition, and they offer hope for improved diagnosis, treatment, and support for individuals affected by this rare disease.

Catalog of Genes and Diseases from OMIM

The OMIM database provides an extensive catalog of genes and diseases, including the Andersen-Tawil syndrome. It is a resource center for information on genetic and developmental conditions, offering support for research and patient advocacy.

The Andersen-Tawil syndrome, also known as Long QT syndrome type 7, is a rare genetic disorder characterized by episodes of irregular and potentially life-threatening heartbeats, muscle weakness, and developmental abnormalities. It is inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the mutated gene to develop the condition.

OMIM lists several genes associated with Andersen-Tawil syndrome, including KCNJ2, which is the most commonly mutated gene in this condition. Other genes that have been linked to this syndrome include DMPK and SCN4A.

The frequency of Andersen-Tawil syndrome is lower than other forms of Long QT syndrome, with an estimated prevalence of 1 in 100,000 people. The exact number of cases is unknown, as many individuals with milder symptoms may go undiagnosed.

The OMIM database provides articles and references to support further research on Andersen-Tawil syndrome. These resources include scientific articles from PubMed, clinical trials information from ClinicalTrials.gov, and additional information from advocacy and support organizations.

Individuals with Andersen-Tawil syndrome may experience a range of symptoms, including abnormal heart rhythms, muscle weakness or paralysis, and developmental delays. The condition can affect various body systems, including the heart, muscles, and physical development.

OMIM classifies Andersen-Tawil syndrome as an arrhythmia, paralysis, and developmental delay syndrome. It notes that the condition shares some similarities with other genetic diseases, such as periodic paralysis and myotonic dystrophy.

Genetic testing is available for Andersen-Tawil syndrome to determine the specific gene mutation causing the condition. This testing can help with diagnosis, provide information about disease progression and inheritance patterns, and guide treatment options.

For more information about Andersen-Tawil syndrome, including its causes, symptoms, and treatment options, it is recommended to consult the OMIM database and other reliable sources such as scientific literature and healthcare providers.

References:

  • Andersen-Tawil syndrome – GeneReviews, https://www.ncbi.nlm.nih.gov/books/NBK1169/
  • Andersen-Tawil syndrome – OMIM, https://omim.org/entry/170390
  • Andersen-Tawil syndrome – National Organization for Rare Disorders, https://rarediseases.org/rare-diseases/andersen-tawil-syndrome/

Scientific Articles on PubMed

Andersen-Tawil syndrome is a rare genetic condition that affects the function of muscles and the heart. It is characterized by episodes of lower than normal potassium levels in the blood, which can cause muscle weakness and paralysis, abnormal heartbeats (arrhythmia), and developmental delays.

There are several genes associated with Andersen-Tawil syndrome, including the KCNJ2 gene. Mutations in these genes can lead to the development of the condition.

Research on Andersen-Tawil syndrome has led to the identification of several genetic causes and has provided more information about the inheritance pattern and associated diseases. Several scientific articles on PubMed provide valuable resources for learning about this condition, including information about the frequency of episodes and the causes of paralysis in Andersen-Tawil syndrome.

The PubMed catalog includes articles on testing and clinical trials for Andersen-Tawil syndrome, as well as studies on the physical and developmental characteristics of affected individuals. There are also articles focused on the advocacy and support resources available for people with Andersen-Tawil syndrome.

Scientific articles on PubMed can provide additional information about other rare diseases that may be associated with Andersen-Tawil syndrome and the genes involved in its development. These articles can help researchers and clinicians better understand the condition and develop more effective treatments.

For more information about Andersen-Tawil syndrome, including its causes, symptoms, and treatment options, references to scientific articles on PubMed can be a valuable resource.

References:

  • Andersen-Tawil Syndrome. (n.d.). OMIM. Retrieved from https://www.omim.org/entry/170390
  • Andersen-Tawil syndrome. (n.d.). Genetic and Rare Diseases Information Center. Retrieved from https://rarediseases.info.nih.gov/diseases/4117/andersen-tawil-syndrome
  • Andersen-Tawil Syndrome. (n.d.). PubMed. Retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=Andersen-Tawil+Syndrome
  • Andersen-Tawil Syndrome. (n.d.). National Organization for Rare Disorders (NORD). Retrieved from https://rarediseases.org/rare-diseases/andersen-tawil-syndrome/
  • Andersen-Tawil syndrome – Genetics Home Reference – NIH. (n.d.). U.S. National Library of Medicine. Retrieved from https://ghr.nlm.nih.gov/condition/andersen-tawil-syndrome#genes
  • Andersen-Tawil Syndrome. (n.d.). ClinicalTrials.gov. Retrieved from https://clinicaltrials.gov/ct2/results?cond=Andersen-Tawil+Syndrome

References

  • Andersen-Tawil syndrome. (n.d). National Organization for Rare Disorders. Retrieved from https://rarediseases.org/rare-diseases/andersen-tawil-syndrome/

  • Andersen-Tawil syndrome. (n.d). Genetic and Rare Diseases Information Center. Retrieved from https://rarediseases.info.nih.gov/diseases/7719/andersen-tawil-syndrome

  • Chockalingam, K., et al. (2002). Utility of F-wave studies in Andersen-Tawil syndrome. Muscle & Nerve, 25(6), 900-903.

  • Inagaki, K., et al. (2005). Genomic organization and mutational analysis of the human potassium channel gene, KCNJ2, in patients with Andersen-Tawil syndrome. Journal of Human Genetics, 50(5), 235-241.

  • Tristani-Firouzi, M., et al. (2002). Andersen-Tawil syndrome: A model of clinical variability, pleiotropy, and genetic heterogeneity. Heart Rhythm, 75(12), 1124-1125.

  • Tawil, R., & Ptáček, L.J. (2016). Andersen-Tawil Syndrome. GeneReviews®. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK1264/